Figure 7.

Safety outcomes of routine blood count, liver and kidney functions. The levels of white blood cell (a), hemoglobin (b), platelets (c), lymphocyte (d), alanine aminotransferase (e), aspartate aminotransferase (f), blood urea nitrogen (g), and serum creatinine (h) showed no significant difference before and after IL-2 treatment. Within-group comparisons were made using the paired-samples t test before (blue) and after (red) IL-2 therapy. Asymptotic significances (2-sided tests) were displayed. The significance level was p < 0.05.

IL-2, interleukin-2.